Philip Charles Hoffman to Carcinoma, Small Cell
This is a "connection" page, showing publications Philip Charles Hoffman has written about Carcinoma, Small Cell.
Connection Strength
0.248
-
Lung cancer. Lancet. 2000 Feb 05; 355(9202):479-85.
Score: 0.172
-
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer. J Clin Oncol. 2004 Mar 15; 22(6):1110-7.
Score: 0.057
-
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood. 1987 Nov; 70(5):1412-7.
Score: 0.018